Caixàs A, Bernà L, Piera J, Rigla M, Matías-Guiu X, Farrerons J, Puig-Domingo M
Department of Endocrinology, Hospital de Sant Pau, Universitat Autònoma de Barcelona, Spain.
Clin Endocrinol (Oxf). 1995 Nov;43(5):525-30. doi: 10.1111/j.1365-2265.1995.tb02915.x.
The use of preoperative imaging in patients with hyperparathyroidism remains controversial. Many of the available techniques are insufficiently sensitive and specific to justify their routine use. We have evaluated the sensitivity and specificity of 99mTc-sestamibi scintigraphy in the management of patients with different forms of hyperparathyroidism.
Preoperative imaging evaluation was carried out by scintigraphic detection of pathological parathyroid glands using 99mTc-sestamibi as a radiotracer; confirmation of scan findings was obtained surgically.
A group of 25 patients with primary (n = 21) or secondary (n = 4) hyperparathyroidism were studied. All were considered for surgical treatment.
In all cases parathyroid imaging was carried out by 99mTc-sestamibi scintigraphy together with at least one other imaging technique which included CT-scan, ultrasonography, MRI or 201TI/99mTc subtraction scintigraphy. Blood tests included measurements of total calcium and PTH.
99mTc-sestamibi scintigraphy correctly localized 20 out of 21 adenomas, giving a sensitivity of 95.2%, markedly higher than that obtained with the other imaging techniques (ultrasonography 75%, 201TI/99mTc subtraction scintigraphy 57.1%, CT-scan 41.7% and MRI 33%). Of a total of 17 glands identified surgically as hyperplastic and confirmed by pathological examination, 99mTc-sestamibi scintigraphy showed a positive image in 10, corresponding always to the larger abnormal glands (sensitivity 58.8%, higher than that observed with the other techniques). No false positive images were obtained with 99mTc-sestamibi. All the ectopic adenomas (n = 3) were identified preoperatively, which contributed significantly to the surgical approach.
In patients with hyperparathyroidism, 99mTc-sestamibi scintigraphy may be used as the single imaging technique as it shows a very high sensitivity and specificity in the preoperative localization of pathological parathyroid glands; the benefit of localizing parathyroid tissue prior to surgery in cases of ectopic adenomas clearly indicates that when an imaging procedure is required, this technique may be of great help in the management of hyperparathyroidism.
甲状旁腺功能亢进患者术前影像学检查的应用仍存在争议。许多现有技术的敏感性和特异性不足,无法证明其常规使用的合理性。我们评估了99mTc-甲氧基异丁基异腈闪烁扫描术在不同类型甲状旁腺功能亢进患者管理中的敏感性和特异性。
术前影像学评估通过使用99mTc-甲氧基异丁基异腈作为放射性示踪剂对病理性甲状旁腺进行闪烁扫描检测来进行;通过手术获得扫描结果的确认。
研究了一组25例原发性(n = 21)或继发性(n = 4)甲状旁腺功能亢进患者。所有患者均考虑接受手术治疗。
在所有病例中,甲状旁腺成像通过99mTc-甲氧基异丁基异腈闪烁扫描术以及至少一种其他成像技术进行,其他成像技术包括CT扫描、超声检查、MRI或201Tl/99mTc减影闪烁扫描术。血液检查包括总钙和甲状旁腺激素的测量。
99mTc-甲氧基异丁基异腈闪烁扫描术正确定位了21个腺瘤中的20个,敏感性为95.2%,明显高于其他成像技术(超声检查为75%,201Tl/99mTc减影闪烁扫描术为57.1%,CT扫描为41.7%,MRI为33%)。在手术中确定并经病理检查证实为增生的总共17个腺体中,99mTc-甲氧基异丁基异腈闪烁扫描术在10个腺体中显示出阳性图像,始终对应于较大的异常腺体(敏感性为58.8%,高于其他技术观察到的敏感性)。99mTc-甲氧基异丁基异腈未获得假阳性图像。所有异位腺瘤(n = 3)均在术前被识别,这对手术方法有显著贡献。
在甲状旁腺功能亢进患者中,99mTc-甲氧基异丁基异腈闪烁扫描术可作为单一成像技术使用,因为它在病理性甲状旁腺术前定位中显示出非常高的敏感性和特异性;在异位腺瘤病例中术前定位甲状旁腺组织的益处清楚地表明,当需要进行成像检查时,该技术在甲状旁腺功能亢进的管理中可能有很大帮助。